Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia.

Sinclair, Paul B; Cranston, Ruth E; Raninga, Prahlad; Cheng, Joanna; Hanna, Rebecca; Hawking, Zoe; Hair, Steven; Ryan, Sarra L; Enshaei, Amir; Nakjang, Sirintra; Rand, Vikki; Blair, Helen J; Moorman, Anthony V; Heidenreich, Olaf; Harrison, Christine J

Sinclair, Paul B; Cranston, Ruth E; Raninga, Prahlad; Cheng, Joanna; Hanna, Rebecca; Hawking, Zoe; Hair, Steven; Ryan, Sarra L; Enshaei, Amir; Nakjang, Sirintra; Rand, Vikki; Blair, Helen J; Moorman, Anthony V; Heidenreich, Olaf; Harrison, Christine J.

Affiliation

Sinclair PB; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle-Upon-Tyne, UK. Paul.Sinclair@newcastle.ac.uk.
Cranston RE; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle-Upon-Tyne, UK.
Raninga P; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle-Upon-Tyne, UK.
Cheng J; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle-Upon-Tyne, UK.
Hanna R; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle-Upon-Tyne, UK.
Hawking Z; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle-Upon-Tyne, UK.
Hair S; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle-Upon-Tyne, UK.
Ryan SL; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle-Upon-Tyne, UK.
Enshaei A; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle-Upon-Tyne, UK.
Nakjang S; Bioinformatics Support Unit, Faculty of Medical Science, Newcastle University, Newcastle-Upon-Tyne, UK.
Rand V; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle-Upon-Tyne, UK.
Blair HJ; School of Health and Life Sciences, Teesside University, Middlesborough, UK.
Moorman AV; National Horizons Centre, Teesside University, Darlington, UK.
Heidenreich O; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle-Upon-Tyne, UK.
Harrison CJ; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle-Upon-Tyne, UK.

Leukemia ; 37(3): 636-649, 2023 03.

Article de En | MEDLINE | ID: mdl-36670235

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteurs de transcription Forkhead / Leucémie-lymphome lymphoblastique à précurseurs B et T Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Leukemia Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google